Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ICON Public : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION (Form 6-K)

06/16/2021 | 04:20pm EDT
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in any doubt as to the action to be taken, you should consult with your independent financial adviser who, if you are taking advice in the Republic of Ireland, is authorised or exempted under the European Communities (Markets in Financial Instruments) Regulations 2017 or the Investment Intermediaries Act, 1995.

If you have sold or transferred your entire holding of ordinary shares in ICON, please pass this document, together with the attached proxy form, to the purchaser or transferee, or to the stockbroker, bank or other agent through whom the sale was effected, for transmission to the purchaser or transferee as soon as possible.


16 June, 2021
To: All ICON Shareholders

NOTICE OF ANNUAL GENERAL MEETING

Dear Shareholder

The Annual General Meeting of ICON plc will be held at 12.00pm (Dublin time) on 20 July 2021 at ICON's global headquarters in South County Business Park, Leopardstown, Dublin 18, Ireland (the AGM).

This letter provides an update on the progress of the previously announced PRA Health Sciences, Inc. acquisition and outlines the background to and summarises the resolutions to be proposed at the AGM. Please refer to the form of proxy for the AGM (which is separately enclosed) and the notes on pages 10 to 13 for details on how to vote your shares and return your form of proxy. Your attention is also drawn to the notice of the AGM on pages 6 to 9 which sets out the matters to be considered at the AGM.

Please ensure that you have read the important notice regarding the measures and procedures we have put in place for the AGM in relation to the COVID-19 pandemic which is contained at the bottom of the notice of the AGM on page 9 and in the notes on pages 10 to 13.

Update on the PRA Acquisition

As announced on February 24, 2021, ICON agreed to acquire PRA Health Sciences, Inc. (PRA) (the Acquisition). ICON expects the Acquisition to close on July 1, 2021. We have received all required regulatory approvals and, on June 15, 2021, the ICON shareholders and PRA stockholders both passed the necessary resolutions to approve the Acquisition.

As provided for in the terms of the Acquisition, the Board of Directors (the Board) have appointed Mr. Colin Shannon (current PRA Chairman and Chief Executive Officer) and Dr. Linda Grais (current PRA non-executive Director) as members of the Board subject to, conditional upon and effective from the completion of the Acquisition.

Election/ Re-election of Directors (ordinary resolutions 1.1 to 1.3 and 2.1 to 2.2)

In accordance with our Constitution (by-laws), one third of the members of the Board who are subject to retirement by rotation shall retire from office and may stand for re-election at the AGM. Accordingly, the following directors will stand for re-election:

-Mr. Ciaran Murray - Chair;

-Ms. Joan Garahy - non-executive Director; and

-Mr. Eugene McCague - non-executive Director.

In addition, Mr. Colin Shannon and Dr. Linda Grais, whose appointments as non-executive directors of ICON are subject to, conditional upon and effective from the completion of the Acquisition will offer themselves for election if they have been appointed to the Board prior to the AGM. Resolutions 2.1 and 2.2 are only capable of being validly passed, and therefore will only be put to a vote of shareholders, if completion of the Acquisition has occurred before the start of the AGM. If completion of the Acquisition has not occurred before the start of the AGM, the Chair of the AGM will not put Resolutions 2.1 and 2.2 to a vote of the shareholders.
2
ICON plc - Notice of Annual General Meeting 2021



Mr. Ciaran Murray, Ms. Joan Garahy, Dr. Linda Grais and Mr. Eugene McCague are 'independent' non-executive Directors (as that term is defined under the published listing requirements of NASDAQ).

Each of the Directors standing for election or re-election demonstrates the necessary commitment to the role and provides valuable skills, knowledge and experience and makes important contributions to the working of the Board or, for the former directors of PRA, have made an important contribution in their previous roles on the board of PRA. Further information on the experience, qualifications and industry knowledge of the current Directors is available from the Annual Report and/or Form 20-F at https://investor.iconplc.com/financials-filings/annual-reports, the biographies of the incoming directors are set out below and the details of current committee composition is set out on our website at https://investor.iconplc.com/corporate-governance/committee-composition.

Incoming Directors' Biographies

Colin Shannon

On January 1, 2010, Mr. Shannon was named PRA's President and Chief Executive Officer and as a director of the PRA. He is currently the Chairman of PRA. Mr. Shannon joined PRA in 2007, serving first as President and Chief Operating Officer. Prior to joining PRA, he was Executive Vice President, Global Clinical Operations at Pharmaceutical Product Development, Inc. (now known as PPD, Inc.), or PPD. During his 12 year tenure with PPD, he held various leadership roles, including Chief Operating Officer for its European division and Chief Financial and Administration Officer for Europe and the Pacific Rim. Prior to joining PPD, Mr. Shannon had more than 15 years of experience in a variety of financial and accounting positions in the utility and multimedia industries. Mr. Shannon earned his M.B.A. from London's City University and is a fellow member of the Chartered Association of Certified Accountants.

Linda S. Grais, M.D.
A director of PRA since October 2015, Dr. Grais served as a member of the board of directors of Ocera Therapeutics, Inc. from January 2008 through December 2017 and as President and Chief Executive Officer of Ocera Therapeutics, Inc., a biopharmaceutical company, from June 2012 to December 2017. Prior to her employment by Ocera Therapeutics, Dr. Grais served as a managing member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company focusing on new treatments for cancer. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich & Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. She currently serves on the boards of directors of Corvus Pharmaceuticals, Inc., Zosano Pharma Corporation and Arca Biopharma, Inc.. She sits on the audit committees of Corvus Pharmaceuticals, Inc., Zosano Pharma Corporation and Arca Biopharma, Inc. and on the compensation committee of Arca Biopharma, Inc. Dr. Grais received a B.A. from Yale University, an M.D. from Yale Medical School and a J.D. from Stanford Law School.

ICON's 2020 Accounts (ordinary resolution 3)
This resolution is to review the Company's affairs and consider ICON's 2020 accounts which have been audited by KPMG, ICON's independent auditors.

Remuneration of Auditors (ordinary resolution 4)
This resolution authorises the Directors to fix the remuneration of the auditors.

3
ICON plc - Notice of Annual General Meeting 2021



Authority to issue shares up to 20% of share capital (ordinary resolution 5)
This resolution authorises the Directors to issue shares until the earlier of the next Annual General Meeting of the Company or 19 January 2023 up to an aggregate of 20%of the share capital of the Company without further shareholder approval. This resolution is required under Irish law as the Company is an Irish incorporated company. The 20% cap on this resolution aligns the resolution with the NASDAQ rules which provide that up to 20% of share capital can be issued without shareholder approval.

Authority to issue shares up to 5% of share capital without offering to existing shareholders, with an additional 5% for funding capital investment or acquisitions (special resolution 6 and special resolution 7)
Resolution 6 authorises the Directors to issue shares for cash, subject to resolution 5, until the earlier of the next Annual General Meeting of the Company or 19 January 2023 up to an aggregate of 5% of the share capital of the Company without having to offer the shares to existing shareholders on a pro rata basis. Resolution 7 authorises the Directors to issue an additional 5% of the share capital for cash, again subject to Resolution 5, on a non pre-emptive basis provided that the proceeds of any such share issuance are to be used only for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment.

A resolution authorising the issuance of shares for cash without such offer round is a requirement of Irish law and there is no such requirement under the applicable U.S. Securities and Exchange Commission (the SEC) rules and NASDAQ rules. As above, this year the authorities under these resolutions expire on the earlier of the next Annual General Meeting of the Company or 19 January 2023.

The caps on resolutions 5, 6 and 7 are different but complementary and they provide our shareholders with significant anti-dilution protection far in excess of similar protections provided to the shareholders of many other NASDAQ-listed companies. Every year since the Company was listed (apart from 2014 as resolutions with 5 year authority were passed in 2013), the Directors have put resolutions to authorise the issuance of shares and to disapply offer round to the shareholders and each such resolution has been passed.

Authority to buy back shares up to 10% of share capital (special resolution 8)
This resolution authorises the Company to purchase in the market (buy-back) up to 10% of the outstanding share capital of the Company. It is important both for the Company and shareholders that the Company has this flexibility to implement a buy-back (without having to seek further shareholder approval) if the market conditions favour a buy-back. It should also be noted that while the applicable SEC rules and NASDAQ rules do not require shareholder approval prior to a share buy-back, this resolution is required as the Company is an Irish incorporated company and Irish law requires shareholders to pass such a resolution to give Directors the authority to put a buy-back in place. The authority under this resolution expires on the earlier of the next Annual General Meeting and 19 January 2023.

Authority to reissue shares held as treasury shares (special resolution 9)
This resolution authorises the price range at which the Company can reissue shares that it holds as treasury shares.Any share buy-back activity by the Company will result in ordinary shares either being cancelled or reissued as treasury shares. We may reissue treasury shares that we acquire through our proposed share buy-back activities including in connection with our executive compensation programme, our employee restricted share unit programme and our other compensation programmes. As a result of using this authority in this way, ICON would avoid the need to issue new shares (and the resulting shareholder dilution) when the vesting of equity awards triggers the requirement to issue shares.
4
ICON plc - Notice of Annual General Meeting 2021



The authority being sought from shareholders provides that the minimum and maximum prices at which an ordinary share held in treasury may be reissued are 95% and 120%, respectively, of the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance. Any reissuance of treasury shares will be at price levels that the Board considers in the best interests of our shareholders.

There is no resolution dealing with executive compensation as ICON, being a foreign private issuer, is not obliged to provide a 'say on pay' shareholder resolution on executive compensation. Details of ICON's executive officers compensation for 2020 are available in the Annual Report and Form 20-F for 2020 which are available at https://investor.iconplc.com/financials-filings/annual-reports.

Approval of Resolutions
Resolutions 1.1 to 1.3, 2.1 to 2.2, 3, 4 and 5 are ordinary resolutions which require approval of a simple majority of the votes cast in person or by proxy and resolutions 6 to 9 are special resolutions which require approval of 75% of the votes cast in person or by proxy.

Recommendation of Directors
Your Board believes that the resolutions to be proposed at the AGM are in the best interests of the Company and its shareholders. Accordingly, your Directors unanimously recommend that you vote in favour of all resolutions as they intend to do in respect of the shares held by them. On 10 June 2021, the Directors held 620,640 ordinary shares representing approximately 1.2% of the issued ordinary share capital of the Company.

Yours sincerely,


Ciaran Murray
Chair

5
ICON plc - Notice of Annual General Meeting 2021



ICON plc
South County Business Park,
Leopardstown,
Dublin 18, Ireland
+353-1-291-2000
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON 20 JULY, 2021
To the Shareholders of ICON plc:

NOTICE is hereby given that the Annual General Meeting of the Company will be held at ICON's global headquarters in South County Business Park, Leopardstown, Dublin 18, Ireland on 20 July 2021 at 12.00pm (Dublin time) (the AGM).

ORDINARY BUSINESS

To consider and, if thought fit, pass the following ordinary resolutions:

1.To re-elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:

1.1 Mr. Ciaran Murray;
1.2 Ms. Joan Garahy; and
1.3 Mr. Eugene McCague.

2.Subject to and conditional upon completion of the acquisition by ICON of PRA Health Sciences, Inc. having occurred before the start of the AGM, to elect, by separate resolutions, the following individuals who retire as Directors in accordance with the Constitution of the Company and, being eligible, offer themselves for re-election:

2.1 Mr. Colin Shannon; and
2.2 Dr. Linda Grais.
3.To review the Company's affairs and consider the accounts for the year ended 31st December 2020 and the reports of the Directors and auditors thereon.

4.To authorise the Directors to fix the remuneration of the auditors.

SPECIAL BUSINESS

To consider and, if thought fit, pass the following ordinary resolution:

5.'That the Directors be and are hereby generally and unconditionally authorised, pursuant to Section 1021 of the Companies Act 2014, to exercise all the powers of the Company to allot relevant
6
ICON plc - Notice of Annual General Meeting 2021


securities (within the meaning of Section 1021 of the Companies Act 2014) up to an aggregate nominal amount of €635,496.76 representing approximately 20% of the aggregate nominal value of the issued ordinary share capital of the Company as at 10 June 2021 and the authority conferred by this resolution shall (a) expire on the earlier of the date of the next Annual General Meeting of the Company or 19 January 2023, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired and (b) be without prejudice and in addition to the authority under the said Section 1021 granted to the Directors pursuant to an ordinary resolution passed at an extraordinary meeting of ICON held on 15 June 2021.'

To consider and, if thought fit, pass the following special resolutions:

6.'That, subject to the passing of Resolution 5, the Directors be and are hereby empowered pursuant to Section 1022 and Section 1023(3) of the Companies Act 2014, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment up to an aggregate nominal amount of €158,874.19 representing approximately 5% of the aggregate nominal value of the issued ordinary share capital of the Company as at 10 June 2021 and the authority conferred by this Resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 19 January 2023, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.'

7.'That subject to the passing of Resolution 5, the Directors be and they are hereby authorised in addition to any authority granted under Resolution 6, to allot equity securities (as defined in Section 1023 of the Companies Act 2014) for cash as if the provisions of sub-section (1) of the said Section 1022 did not apply to any such allotment provided that:

(i)The proceeds of any such allotment are to be used for the purposes of financing (or refinancing, if the authority is to be used within six months after the original transaction) an acquisition or other capital investment; and

(ii)The nominal value of all equity securities allotted pursuant to this authority together with the nominal value of all treasury shares (as defined in Section 106 of the Companies Act 2014) reissued pursuant to Resolution 8 not exceed €158,874.19 representing approximately 5% of the nominal value of the issued share capital as at 10 June 2021.

The authority conferred by this resolution shall expire on the earlier of the date of the next Annual General Meeting of the Company or 19 January 2023, unless previously renewed, varied or revoked; provided that the Company may make an offer or agreement before the expiry of the authority conferred by this resolution, which would or might require any such securities to be allotted after the authority conferred by this resolution has expired and, in that case, the Directors may allot relevant securities in pursuance of any such offer or agreement as if the authority conferred hereby had not expired.'

8.'That the Company and/or any subsidiary (as such expression is defined by Section 7 of the Companies Act 2014) of the Company be and they are hereby generally authorised to make overseas
7
ICON plc - Notice of Annual General Meeting 2021


market purchases (as defined by Section 1072(2) of the Companies Act 2014) of shares of any class of the Company on such terms and conditions and in such manner as the Directors or, as the case may be, the Directors of such subsidiary, may from time to time determine in accordance with and subject to the provisions of the Companies Act 2014 and the following restrictions and provisions:

(i)The maximum aggregate number of shares authorised to be acquired pursuant to this resolution shall not exceed 10% of the aggregate number of shares issued by the Company at close of business on the date of passing of this resolution;

(ii)The minimum price (exclusive of expenses) which may be paid for any such share shall be an amount equal to the nominal value thereof; and

(iii)The maximum price (exclusive of expenses) to be paid for any ordinary share shall be an amount equal to 115% of the NASDAQ Official Close Price (the 'NOCP') (as reported by NASDAQ) of the Company's ordinary shares on the trading day preceding the day on which the relevant shares are purchased by the Company.

The authority hereby conferred shall expire on the earlier of the date of the next Annual General Meeting of the Company or 19 January 2023 or (if earlier) unless previously varied, revoked or renewed in accordance with the provisions of Section 1074 of the Companies Act 2014. The Company or any subsidiary may before such expiry make a contract for the purchase of shares which would or might be wholly or partly executed after such expiry and may make a purchase of shares pursuant to any such contract as if the authority hereby conferred had not expired.'

9. 'That the reissue price range at which any treasury shares held by the Company may be reissued off-market shall be as follows:

(i) the maximum price at which such treasury share may be reissued off-market shall be an amount equal to 120% of the 'market price'; and

(ii) the minimum price at which a treasury share may be reissued off-market shall be the nominal value of the share where such a share is required to satisfy an obligation under an employee share plan operated by the Company or, in all other cases, an amount equal to 95% of the 'market price'; and

(iii) for the purposes of this resolution, the 'market price' shall mean the average closing price per ordinary share of the Company, as reported by NASDAQ, for the thirty (30) trading days immediately preceding the proposed date of reissuance.

The authority hereby conferred to reissue treasury shares shall expire eighteen months from the date of the passing of this resolution unless previously varied or renewed in accordance with the provisions of Section 1078 of the Companies Act 2014.'

8
ICON plc - Notice of Annual General Meeting 2021



By Order of the Board of Directors,
Diarmaid Cunningham
Company Secretary

Dublin, Ireland
Dated: 16 June, 2021
Your vote is important. ICON shareholders are requested to complete, date, sign and return the enclosed proxy in the envelope provided, or to submit their votes electronically through the Internet or by telephone.

In light of public health concerns related to COVID-19, ICON would like to emphasize that it considers the health of its shareholders, employees, attendees and other stakeholders a top priority and in this context is closely monitoring the evolving COVID-19 situation as regards attendance at the AGM. Shareholders are referred to the Notes section which sets out further detail on the public health situation in Ireland and current restrictions around in person attendance at the ICON offices. ICON therefore strongly encourages voting via mail, telephone and Internet over in person attendance at the AGM.

9
ICON plc - Notice of Annual General Meeting 2021


NOTES:

1. Information and Documentation
Information regarding the Annual General Meeting is available on the Company's website www.iconplc.comand from www.proxyvote.com. If you require a paper copy of the Form 20-F or Annual Report, please contact Investor Relations at 1-888-381-7923 or IR@iconplc.com.

2. Who is eligible to vote and how?
The record date for the Annual General Meeting is 10 June 2021.

If your shares are registered in your name, you are a shareholder of record. Shareholders of record who are entered in the Register of Members of the Company on 10 June 2021 shall be entitled to attend, speak, ask questions and vote at the Annual General Meeting, or if relevant, any adjournment thereof. Changes in the Register of Members of the Company after that time will be disregarded in determining the right of any person to attend and/or vote at the Annual General Meeting.

For those shareholders whose shares are not held in their name, but rather in an account at a brokerage firm, bank, dealer or other similar organisation, who in turn hold through The Depository Trust Company ('DTC'), then their entitlement to vote is determined as at 10 June 2021.

Depending on whether your shares are registered in your name or whether your shares are held in a 'street name' the arrangements are as follows:
Shareholder of Record: Shares Registered in Your Name
In light of public health concerns related to COVID-19, ICON would like to emphasize that it considers the health of its shareholders, employees, attendees and other stakeholders a top priority and in this context is closely monitoring the evolving COVID-19 situation as regards the AGM. Shareholders are referred to the section below entitled 'Attending the AGM' which sets out further detail on the situation in Ireland and restrictions around in person attendance at the ICON offices. ICON therefore strongly encourages voting via mail, telephone and Internet over in person attendance at the ICON AGM.
As a shareholder of record, you may vote in person at the Annual General Meeting or vote by proxy. In the case of joint holders, the vote of the senior member who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other shareholder of record and, for this purpose, seniority shall be determined by the order in which the names stand in the Register of Members of the Company in respect of the joint holding. The appointment of a proxy will not preclude a shareholder of record from attending, speaking, asking questions and voting at the Annual General Meeting should the shareholder subsequently wish to do so. A proxy need not be a member of the Company. If you wish to appoint more than one proxy or a person not listed on the form of proxy, please contact Investor Relations at 1-888-381-7923 or IR@iconplc.com.

A Form of Proxy is enclosed with this notice of Annual General Meeting for shareholders of record. To be effective, the Form of Proxy duly completed and executed, together with any authority under which it is executed, or a copy thereof certified, must be deposited at the registered office of the Company, so as to be received by 11.59pm ET on 19 July 2021 or if the Annual General Meeting is adjourned, on the day that falls before the day appointed for the adjourned meeting or (in the case of a poll taken otherwise than at or on the same day as the Annual General Meeting or adjourned meeting) the day before the taking of the poll at which it is to be used. Any alteration to the Form of Proxy must be initialled by the person who signs it.
10
ICON plc - Notice of Annual General Meeting 2021


Alternatively, provided it is received by 11.59pm ET on 18 July 2021 or if the Annual General Meeting is adjourned, by 11.59pm ET on the day that falls 48 hours before the time appointed for the adjourned meeting or (in the case of a poll taken otherwise than at or on the same day as the Annual General Meeting or adjourned meeting) by 11.59pm ET on the day that falls 48 hours before the taking of the poll at which it is to be used, the appointment of a proxy may be submitted by telephone or electronically, subject to the applicable terms and conditions, using the phone number on the Form of Proxy and following the instructions provided or via the Internet by accessing Broadridge's website www.proxyvote.com and following the instructions on the website. The information you need to appoint your proxy by telephone or electronically is included at the top of your Form of Proxy.

You need only vote in one way (so that, if you vote by Internet or by telephone, you need not return the Form of Proxy). In the case of a corporation, the Form of Proxy must be either executed under seal or signed on its behalf by a duly authorised officer or attorney.
Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent
If, as at 10 June 2021, your shares were not held in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organisation, who in turn hold through The Depository Trust Company ('DTC'), then you are the beneficial owner of shares held in 'street name' and these proxy materials are being forwarded to you by that organisation, together with instructions as to voting. You will need to carefully follow the instructions from your broker, bank or other agent or contact your broker, bank or other agent if you have any queries.

As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account as per the instructions enclosed by your broker. You are also invited to attend the Annual General Meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the Annual General Meeting unless you contact your broker and obtain a valid proxy card from your broker or other agent.

Therefore as a beneficial owner of shares registered in the name of your broker, bank or other agent, who in turn hold the shares through DTC, you should have received a voting instruction card and voting instructions with these proxy materials from that organisation rather than from us. Simply follow the instructions on the voting instruction card provided by your broker, bank or other agent to ensure that your vote is counted.
3. Attending the AGM -Special Precautions Due to COVID-19 Concerns

You are entitled to attend the AGM only if you are a shareholder of record of ICON at the close of business on 10 June, 2021 (the record date for the AGM) or hold a proxy for such a shareholder. Shares held in 'street name' may be voted in person by you only if you obtain a signed legal proxy from your bank, broker or other nominee giving you the right to vote the shares at the AGM.

In light of public health concerns related to COVID-19, ICON would like to emphasize that it considers the health of its shareholders, employees, attendees and other stakeholders a top priority, and in this context, is closely monitoring the evolving COVID-19 situation. ICON therefore strongly encourages voting via mail, telephone and Internet over in person attendance at the ICON AGM.

11
ICON plc - Notice of Annual General Meeting 2021


Based on the latest available public health guidance, it is expected the AGM will proceed under very constrained circumstances given current restrictions on public gatherings in Ireland. Shareholders are strongly encouraged not to attend the meeting in person and instead to vote their shares by proxy as the preferred method of fully and safely exercising their rights. Personal attendance at the AGM may present a health risk to shareholders and others and entry may be refused. ICON advises that shareholders who are experiencing any COVID-19 symptoms or anyone who has been in contact with any person experiencing any COVID-19 symptoms should not attend the AGM in person.

ICON may take additional procedures or limitations applicable to meeting attendees, including restrictions on seating arrangements, health screening requirements and other reasonable or required measures in order to enter the building.

In the event that a change of venue becomes necessary due to public health recommendations regarding containment of COVID-19, which may include the closure of or restrictions on access to the meeting venue, ICON will promptly communicate this to shareholders by an announcement in a press release, on the investor relations page of https://investor.iconplc.com/ and a filing with the U.S. Securities and Exchange Commission. ICON advises shareholders to monitor the page regularly, as circumstances may change on short notice. We recommend that shareholders keep up-to-date with the latest public health guidance regarding travel, self-isolation and health and safety precautions.

4. How many votes do you have?
The total number of issued ordinary shares on the record date, 10 June 2021, was 52,958,063. On a vote on a show of hands, every shareholder present in person and every proxy has one vote (but no individual shall have more than one vote). On a poll, every shareholder present in person and every proxy shall have one vote for every share carrying rights of which he is the holder or proxy. Ordinary resolutions are required to be passed by a simple majority of shareholders voting in person or by proxy. Special resolutions are required to be passed by a majority of 75 per cent of shareholders voting in person or by proxy.

5. Broker Voting
If your shares are held by a broker on your behalf (that is, in 'street name'), and you do not instruct the broker as to how to vote these shares, the broker may not exercise discretion to vote for or against any of the proposals. This would be a 'broker non-vote' and these shares will not be counted as having been voted on the proposals. Please instruct your bank or broker so your vote can be counted.

6. Can I change my vote after submitting my proxy?
Shareholder of Record: Shares Registered in Your Name
Yes. You can revoke your proxy at any time before the final vote at the Annual General Meeting. If you are the record holder of your shares, you may revoke your proxy in any one of three ways:
•You may submit another properly completed proxy with a later date. Your revised proxy must be received before the commencement of the Annual General Meeting at 12.00pm Dublin time on 20 July 2021 or if the Annual General Meeting is adjourned, before the commencement of the adjourned meeting;

•You may send a written notice that you are revoking your proxy to Erina Fox, Deputy Company Secretary, ICON plc at the registered office of the Company (being South County Business Park, Leopardstown, Dublin 18, Ireland) or by email to IR@iconplc.com. Your notice must be received before the commencement of the Annual General Meeting at
12
ICON plc - Notice of Annual General Meeting 2021


12.00pm Dublin time on 20 July 2021 or if the Annual General Meeting is adjourned, before the commencement of the adjourned meeting; or

•You may attend the Annual General Meeting and vote in person.

Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent
If your shares are held by your broker, bank or other agent, you should follow the instructions provided by them. Please contact your broker, bank or other agent if you have any queries.

7. What does it mean if I receive more than one set of materials?
If you receive more than one set of materials, your shares are registered in more than one name or are registered in different accounts. In order to vote all the shares you own, you must sign and return all of the proxy cards or follow the instructions for any alternative voting procedure on each of the proxy cards you receive.
13
ICON plc - Notice of Annual General Meeting 2021

Disclaimer

ICON plc published this content on 16 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 June 2021 20:19:01 UTC.


ę Publicnow 2021
All news about ICON PUBLIC LIMITED COMPANY
09:18aICON PUBLIC : Deutsche Bank Adjusts ICON Price Target to $234 From $212 on Q2 Be..
MT
07/23ICON PUBLIC : Citigroup Upgrades ICON to Buy from Neutral, Adjusts Price Target ..
MT
07/23ICON PUBLIC : JPMorgan Adjusts ICON's Price Target to $230 from $215, Keeps Neut..
MT
07/23ICON PUBLIC : Baird Adjusts ICON's Price Target to $265 From $260, Keeps Outperf..
MT
07/23ICON PUBLIC : Wells Fargo Adjusts Price Target on ICON to $280 From $250, Mainta..
MT
07/23ICON PUBLIC : Credit Agreement (Form 6-K)
PU
07/22ICON PUBLIC : reports second quarter 2021 financial results
AQ
07/21ICON PUBLIC : Posts Higher Q2 Results from Year Ago, Updates Guidance -- Stock D..
MT
07/21ICON PUBLIC : Reports Second Quarter 2021 Results (Form 6-K)
PU
07/21ICON PUBLIC : Q2 2021 Earnings Call Slides Final.pdf
PU
More news
Financials (USD)
Sales 2021 5 425 M - -
Net income 2021 475 M - -
Net Debt 2021 5 169 M - -
P/E ratio 2021 31,4x
Yield 2021 -
Capitalization 11 545 M 11 545 M -
EV / Sales 2021 3,08x
EV / Sales 2022 2,15x
Nbr of Employees 16 480
Free-Float 99,2%
Chart ICON PUBLIC LIMITED COMPANY
Duration : Period :
ICON Public Limited Company Technical Analysis Chart | ICLR | IE0005711209 | MarketScreener
Technical analysis trends ICON PUBLIC LIMITED COMPANY
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 218,00 $
Average target price 248,62 $
Spread / Average Target 14,0%
EPS Revisions
Managers and Directors
Stephen A. Cutler Chief Executive Officer & Executive Director
Brendan Brennan Chief Financial Officer
Ciaran Murray Executive Chairman
Tom O'Leary Chief Information Officer
Kristen K. Buck Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ICON PUBLIC LIMITED COMPANY11.81%11 479
MODERNA, INC.233.90%88 312
LONZA GROUP AG24.05%53 538
IQVIA HOLDINGS INC.39.02%47 022
CELLTRION, INC.-26.46%32 170
SEAGEN INC.-16.87%28 525